CymitQuimica logo

CAS 1505515-69-4

:

Fórmula:C29H34FN5O5
InChI:InChI=1S/C23H24FN5O.C6H10O4/c1-15(25)14-30-20-8-6-17(7-9-20)21-13-26-23-11-10-22(28-29(21)23)27-16(2)18-4-3-5-19(24)12-18;7-5(8)3-1-2-4-6(9)10/h3-13,15-16H,14,25H2,1-2H3,(H,27,28);1-4H2,(H,7,8)(H,9,10)/t15-,16-;/m1./s1
Chave InChI:DORJQZDOULKINH-QNBGGDODSA-N
SMILES:C[C@H](COC1=CC=C(C=C1)C2=CN=C3N2N=C(C=C3)N[C@H](C)C4=CC(=CC=C4)F)N.C(CCC(=O)O)CC(=O)O
Foram encontrados 5 produtos.
  • Taletrectinib

    CAS:
    Taletrectinib
    Fórmula:C29H34FN5O5
    Pureza:99.5%
    Peso molecular:551.61

    Ref: 54-BUP03569

    5mg
    225,00€
    10mg
    343,00€
    25mg
    524,00€
    50mg
    759,00€
    100mg
    1.028,00€
    200mg
    1.304,00€
  • Taletrectinib

    CAS:
    3-(4-((R)-2-Aminopropoxy)phenyl)-N-((R)-1-(3-fluorophenyl)ethyl)imidazo[1,2-b]pyridazin-6-amine adipate
    Fórmula:C29H34FN5O5
    Pureza:99%
    Peso molecular:551.61
  • Taletrectinib

    CAS:
    Taletrectinib (AB-106) is a new-generation selective inhibitor of ROS1/NTRK including ROS1,NTRK1,NTRK2 and NTRK3.
    Fórmula:C29H34FN5O5
    Pureza:99.87% - 99.96%
    Cor e Forma:White Solid
    Peso molecular:551.6092
  • Taletrectinib Adipate

    Produto Controlado
    CAS:
    Fórmula:C29H34FN5O5
    Cor e Forma:Neat
    Peso molecular:551.62

    Ref: TR-T757780

    100mg
    8.040,00€
  • Taletrectinib

    CAS:
    Taletrectinib is a small molecule that inhibits the activity of serine proteases, including caspase-3 and cathepsin B. Taletrectinib binds to the active site of these enzymes, preventing them from cleaving their substrate proteins. It has been shown to have antitumor activity in cell cultures as well as in mice with tumors. This drug has a terminal half-life of about 6 hours in human plasma. The safety profile of taletrectinib is similar to those of other drugs used for cancer treatment. This drug has been tested in phase 1 clinical trials and demonstrated an escalation dose response effect. In addition, it demonstrated a favorable safety profile with limited toxicity profiles. Taletrectinib targets lesions on zymogens that are not accessible by other drugs such as lorlatinib or ibrutinib.br> br> Taletrectinib is also being developed for the treatment of neuroendocrine
    Fórmula:C29H34FN5O5
    Pureza:Min. 95%
    Peso molecular:551.6 g/mol

    Ref: 3D-FKC51569

    5mg
    Descontinuado
    10mg
    Descontinuado
    25mg
    Descontinuado
    50mg
    Descontinuado
    100mg
    Descontinuado
    Produto descontinuado